Our group and others identified citrullinated ENO1 in cancer cells (Jiang et al., 2013; Sanchez et al., 2016), suggesting that this PTM could potentially trigger ENO1 autoantibodies in cancer patients. This evidence concerns the gene ENO1 and cancer.